New counseling approach aims to boost HIV prevention in young black men who have sex with men
NCT ID NCT05087680
First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time
Summary
This study tests a counseling program called ACTPrEP, designed to help young Black men who have sex with men (ages 18-34) start and continue taking PrEP, a daily pill that prevents HIV. The program uses acceptance and commitment therapy to address thoughts and feelings that might get in the way of using PrEP. Participants are randomly assigned to either the ACTPrEP program or a standard PrEP education session, and researchers measure how many people stay in the study and how satisfied they are with the program.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Acceptance and Commitment Therapy (ACT)-based counseling program
- What this could lead to
- If successful, this counseling approach could help more young Black men who have sex with men consistently use PrEP, reducing HIV transmission in a high-risk group.
- What could go wrong
- This is a small, early-stage feasibility study, so results may not apply broadly. The intervention may not improve PrEP use more than standard education.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV PREVENTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Univeristy of Mississippi Medical Center
Jackson, Mississippi, 39216, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a conversation prevent HIV? study tests In-Person vs. online counseling for PrEP uptake
- Could a simple app help pharmacists stop HIV?
- New HIV vaccine strategy aims to prime and boost immune defenses
- Can a standard HIV pill rescue those who got infected on Long-Acting PrEP?
- Can mailed HIV tests help prevent spread among drug users?
- New app could bridge the gap between HIV Self-Testing and PrEP access